An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients

被引:0
|
作者
Park, K
Koh, YB
Kwak, JY
Kim, SJ
Yoon, YS
Kang, CM
Kim, YS
机构
[1] YONSEI UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
[2] CATHOLIC UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
[3] CATHOLIC UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[4] HANYANG UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
[5] HANYANG UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[6] SEOUL NATL UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1202 / 1203
页数:2
相关论文
共 50 条
  • [1] COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS
    SKETRIS, IS
    LAWEN, JG
    BEAUREGARDZOLLINGER, L
    BELITSKY, P
    LANDSBERG, D
    GIVNER, ML
    KEOWN, P
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2961 - 2963
  • [2] Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral
    Chu, SH
    Pang, ST
    Chiang, YJ
    Chuang, CK
    Chen, HW
    Chen, CS
    Chou, CC
    Huang, CC
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3521 - 3523
  • [3] Conversion from Sandimmune to Neoral in stable renal transplant recipients
    Pescovitz, MD
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2196 - 2198
  • [4] Neoral conversion study: Shift from sandimmune classic formulation to sandimmune neoral in heart and lung transplant patients
    Svendsen, U
    Larsen, K
    Allermand, H
    Thayssen, P
    Jensen, S
    Pettersson, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3477 - 3477
  • [5] Comparison of neoral and sandimmune preparations in renal transplant patients - Improved pharmacokinetics with neoral
    Warrens, AN
    Salama, A
    Waters, JB
    Lechler, RI
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2169 - 2170
  • [6] Conversion from cyclosporine sandimmune to cyclosporine neoral in the stable renal transplant population
    Griffin, PJA
    Moore, RH
    Jurewicz, WA
    Lord, RHH
    Webley, Y
    Jenkins, J
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 303 - 303
  • [7] ECONOMIC-ANALYSIS OF SANDIMMUNE-NEORAL IN CANADA IN STABLE RENAL-TRANSPLANT PATIENTS
    KEOWN, P
    LAWEN, JG
    LANDSBERG, D
    BEAUREGARDZOLLINGER, L
    RIVIERE, M
    LECLERC, C
    HARDENS, M
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (02) : 1845 - 1848
  • [8] Conversion from conventional Sandimmune to Neoral therapy in stable renal transplant recipients
    Lokkegaard, H
    Asmundsson, P
    Clausen, P
    Dieperink, H
    Hansen, JM
    Heaf, J
    Jensen, SB
    Kornerup, HJ
    Madsen, S
    Pedersen, EB
    Poulsen, JV
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2199 - 2201
  • [9] Renal function after conversion from Sandimmune to Neoral in stable renal transplant recipients.
    Hricik, DE
    Bartucci, MR
    Knauss, TC
    Schulak, JA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3327 - A3327
  • [10] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327